Is Alzheimer’s Caused By Viruses?

April 21, 2022Neelem Sheikh

The theory that suggests common viral or bacterial infections could potentially cause Alzheimer’s disease has left many patients on edge. While this so-called “Fringe Theory” linking viruses and other microbes to Alzheimer’s was first proposed more than 30 years ago, it has gained traction over the past several years.

While we do know the immune system plays a key role in the development of Alzheimer’s disease, there is not enough evidence to support a hypothesis that suggests Alzheimer’s is caused by viruses or other types of infections.

Below, we provide information on the theory that Alzheimer’s is caused by viruses, detailing the infectious hypothesis, types of infections claimed to cause Alzheimer’s disease, and known factors involved in Alzheimer’s development.

Is Alzheimer’s Caused By Viruses?: The Infectious Hypothesis

The infectious hypothesis suggests that some sort of pathogen (such as a virus, bacteria, or prion) is the underlying root cause of Alzheimer’s disease. The theory stems primarily from evidence that some pathogens, such as herpesviruses, are more commonly found in the brains of Alzheimer’s disease patients compared to those without Alzheimer’s.

What Types of Infections Are Claimed to Cause Alzheimer’s?

A few of the infections and viruses being researched due to their connection to Alzheimer’s disease include herpes, pneumonia, and spirochete bacteria.


Herpes simplex virus 1 (HSV-1), also known as oral herpes, causes an infection of the mouth in the form of cold sores. This virus stays in the body for life but remains dormant most of the time. While HSV-1 typically infects the body, it has been found in the brains of both healthy individuals and those with Alzheimer’s disease. However, the HSV-1 virus seems to be more common in those with Alzheimer’s disease who have a risk gene for Alzheimer’s, APOE ε4.


Chlamydia pneumoniae is a respiratory pathogen that causes pneumonia and bronchitis. While it typically infects the respiratory tract, the passage formed by the mouth, nose, throat, and lungs, it can sometimes remain as a chronic infection inside cells. Because this bacteria has been found in the brains of those with Alzheimer’s disease, some researchers have hypothesized that the inflammation caused by the presence of this bacteria may contribute to underlying pathological mechanisms of Alzheimer’s.

Spirochete Bacteria

Spirochetes, such as Borrelia burgdorferi, which causes Lyme disease, and Porphyromonas gingivalis, which causes gum disease, have also been linked to Alzheimer’s disease. Spirochetes are significantly more common in the brains of those with Alzheimer’s disease compared to those without Alzheimer’s. Additionally, chronic gum disease has been identified as a risk factor for Alzheimer’s.

Alzheimer’s as a Multifactorial Disease

While there is currently no known causative agent for Alzheimer’s disease, there are many well-known risk factors. Alzheimer’s disease is believed to be multifactorial, meaning it is not caused by a single factor, like a virus, but rather develops from a combination of several factors, such as age, genetics, and lifestyle, as detailed below.

  • Age: Increasing age is the greatest known risk factor for Alzheimer’s disease, though age itself does not cause Alzheimer’s disease.
  • Genetic factors: Researchers have identified several genes that increase the risk of developing Alzheimer’s disease (risk genes) as well as genetic mutations within specific genes that guarantee the development of Alzheimer’s disease (deterministic genes), though the latter accounts for only 1% of Alzheimer’s cases.
  • Lifestyle factors: Potentially modifiable risk factors for Alzheimer’s disease include, but are not limited to, poor diet and nutrition, a lack of regular exercise, heavy alcohol consumption, poor sleep, a lack of social and mental engagement, hearing loss, cataracts and other causes of visual impairment, vascular conditions, and depression.

Key Takeaways

The truth is you can find correlations between any two things. Just because viruses and other infections are more commonly found in patients with Alzheimer’s disease does not necessarily mean that Alzheimer’s is caused by viruses. Correlation does not imply causation. This is not to say that these viruses have no bearing on Alzheimer’s disease; however, it is more likely that the higher prevalence of such infections in Alzheimer’s disease patients is caused by the higher susceptibility to infection for those with the disease.

To better understand and address the breadth of factors involved in Alzheimer’s disease development, more research will be required in addition to the application of precision medicine approaches. Taking a more precise, personalized approach to neurological diseases, like Alzheimer’s disease, will give rise to a wide range of targeted drugs and therapies that can be effectively used in combination to treat specific neurocognitive impairments (impairments to cognitive and functional aspects of brain function) that present uniquely in neurological disease patients.

Altoida: Paving the Path Towards Precision Neurology

At Altoida, we are dedicated to bringing precision medicine approaches to neurological disease diagnosis and monitoring. We are building the world’s-first Precision Neurology platform and app-based medical device—backed by 11 years of clinical validation—to accelerate and improve drug development, neurological disease research, and patient care.

By completing a series of augmented reality and motor activities designed to simulate complex Activities of Daily Living on a smartphone or tablet, Altoida’s device extracts and provides robust measurements of brain function across 13 neurocognitive domains. Our device measures and analyzes nearly 800 multimodal cognitive and functional digital biomarkers. Through the collection of highly granular data from integrated smartphone or tablet sensors, Altoida’s device produces comprehensive neurocognitive domain scores.

This method, along with our innovative artificial intelligence, will pioneer fully digital predictive neurological disease diagnosis. After our Breakthrough Device designation by the FDA, Altoida’s device will provide patients with a predictive score that will enable a highly accurate prediction of whether a patient aged 55 and older will or will not convert from Mild Cognitive Impairment to Alzheimer’s disease.

 When this score is taken in conjunction with our neurocognitive domain scores, providers will be able to make specific, personalized conclusions about how neurological diseases are uniquely affecting their patients. This, in turn, will enable a personalized precision approach to treatment and care plan development for neurological disease patients.

To learn more about if Alzheimer’s is caused by viruses or about Altoida’s Precision Neurology platform and medical device, contact us today.

Contact Us

At Altoida, we use digital biomarkers to radically change the method of assessing brain health and cognitive diseases. After nearly two decades of research, we are developing a platform and device to measure and analyze cognitive biomarkers associated with cognitive impairment to evaluate perceptual and memory function.
Contact Us

Contact Us

80 M Street SE, Suite 100 Washington, DC 20003 USA 


Follow Us


By visiting our Website and/or using the Services in any manner, you acknowledge that you accept the practices and policies outlined in our Privacy Policy.

Our Disclaimer

@ Altoida 2022